ArticleBioengineering (Basel, Switzerland)2023
Personalized Explanations for Early Diagnosis of Alzheimer's Disease Using Explainable Graph Neural Networks with Population Graphs.
Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- EBV-HSA-RegDB: A database of regulatory interactions between Epstein-Barr virus and human miRNAs.Archives of virology · 2026Article
- From Integrated Care to Learning Systems.Healthcare (Basel, Switzerland) · 2026Review
- Alzheimer's disease detection using a quantum deep neural network with Haralick feature extraction and simulated annealing optimization.PeerJ. Computer science · 2026Article
- Explainable Artificial Intelligence in Neuroimaging of Alzheimer's Disease.Diagnostics (Basel, Switzerland) · 2025Review
- Graph neural networks in Alzheimer's disease diagnosis: a review of unimodal and multimodal advances.Frontiers in neuroscience · 2025Review
- Personalized progression modelling and prediction in Parkinson's disease with a novel multi-modal graph approach.NPJ Parkinson's disease · 2024Article
- Explainable Machine Learning Models for Brain Diseases: Insights from a Systematic Review.Neurology international · 2024Review
- Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer's Disease: A Recent Systematic Review.International journal of molecular sciences · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Leveraging recent advances in graph neural networks, our study introduces an application of graph convolutional networks (GCNs) within a correlation-based population graph, aiming to enhance Alzheimer's disease (AD) prognosis and illuminate the intricacies of AD progression. This methodological approach leverages the inherent structure and correlations in demographic and neuroimaging data to predict amyloid-beta (Aβ) positivity. To validate our approach, we conducted extensive performance comparisons with conventional machine learning models and a GCN model with randomly assigned edges. The results consistently highlighted the superior performance of the correlation-based GCN model across different sample groups in the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset, suggesting the importance of accurately reflecting the correlation structure in population graphs for effective pattern recognition and accurate prediction. Furthermore, our exploration of the model's decision-making process using GNNExplainer identified unique sets of biomarkers indicative of Aβ positivity in different groups, shedding light on the heterogeneity of AD progression. This study underscores the potential of our proposed approach for more nuanced AD prognoses, potentially informing more personalized and precise therapeutic strategies. Future research can extend these findings by integrating diverse data sources, employing longitudinal data, and refining the interpretability of the model, which potentially has broad applicability to other complex diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.